Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1980 Feb;98(2):517–568.

Immunobiologic aspects of the brain and human gliomas. A review.

C J Wikstrand, D D Bigner
PMCID: PMC1903417  PMID: 6986786

Full text

PDF
515

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarli J. A., Aparicio S. R., Lumsden C. E., Tönder O. Binding of normal human IgG to myelin sheaths, glia and neurons. Immunology. 1975 Jan;28(1):171–185. [PMC free article] [PubMed] [Google Scholar]
  2. Akeson R., Seeger R. C. Interspecies neural membrane antigens on cultured human and murine neuroblastoma cells. J Immunol. 1977 Jun;118(6):1995–2003. [PubMed] [Google Scholar]
  3. Albright L., Seab J. A., Ommaya A. K. Intracerebral delayed hypersensitivity reactions in glioblastoma multiforme patients. Cancer. 1977 Mar;39(3):1331–1336. doi: 10.1002/1097-0142(197703)39:3<1331::aid-cncr2820390348>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  4. Antanitus D. S., Choi B. H., Lapham L. W. Immunofluorescence staining of astrocytes in vitro using antiserum to glial fibrillary acidic protein. Brain Res. 1975 May 23;89(2):363–367. doi: 10.1016/0006-8993(75)90729-5. [DOI] [PubMed] [Google Scholar]
  5. Anzil A. P. Glioblastoma multiforme with extracranial metastases in the absence of previous craniotomy. Case report. J Neurosurg. 1970 Jul;33(1):88–94. doi: 10.3171/jns.1970.33.1.0088. [DOI] [PubMed] [Google Scholar]
  6. Arndt R., Stark R., Thiele H. G. Detection and molecular characterization of the thymus-brain antigen in human brain. Immunology. 1977 Jul;33(1):101–107. [PMC free article] [PubMed] [Google Scholar]
  7. BLOOM W. H., CARSTAIRS K. C., CROMPTON M. R., McKISSOCK W. Autologous glioma transplantation. Lancet. 1960 Jul 9;2(7141):77–78. doi: 10.1016/s0140-6736(60)91219-8. [DOI] [PubMed] [Google Scholar]
  8. Balhuizen J. C., Bots G. T., Schaberg A., Bosman F. T. Value of cerebrospinal fluid cytology for the diagnosis of malignancies in the central nervous system. J Neurosurg. 1978 May;48(5):747–753. doi: 10.3171/jns.1978.48.5.0747. [DOI] [PubMed] [Google Scholar]
  9. Becker L. E., Narayan O., Johnson R. T. Studies of human papovavirus tumor antigen in experimental and human cerebral neoplasms. Can J Neurol Sci. 1976 May;3(2):105–109. doi: 10.1017/s0317167100025853. [DOI] [PubMed] [Google Scholar]
  10. Benda P., Lightbody J., Sato G., Levine L., Sweet W. Differentiated rat glial cell strain in tissue culture. Science. 1968 Jul 26;161(3839):370–371. doi: 10.1126/science.161.3839.370. [DOI] [PubMed] [Google Scholar]
  11. Biberfeld G. Antibodies to brain and other tissues in cases of Mycoplasma pneumoniae infection. Clin Exp Immunol. 1971 Feb;8(2):319–333. [PMC free article] [PubMed] [Google Scholar]
  12. Bigner D. D., Fritz R. B., Day E. D. Cerebral physiology in dogs after brain-tumor induction with Schmidt-Ruppin Rous sarcoma virus: experiences with radioiodinated normal and antiviral immunoglobulin G. J Natl Cancer Inst. 1969 Sep;43(3):565–573. [PubMed] [Google Scholar]
  13. Bigner D. D., Olson W. H., McFarlin D. E. Peripheral polyneuropathy, high and low molecular weight IgM, and amyloidosis. Arch Neurol. 1971 Apr;24(4):365–373. doi: 10.1001/archneur.1971.00480340097011. [DOI] [PubMed] [Google Scholar]
  14. Bloom H. J. Combined modality therapy for intracranial tumors. Cancer. 1975 Jan;35(1):111–120. doi: 10.1002/1097-0142(197501)35:1<111::aid-cncr2820350116>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  15. Bloom H. J., Peckham M. J., Richardson A. E., Alexander P. A., Payne P. M. Glioblastoma multiforme: a controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy. Br J Cancer. 1973 Mar;27(3):253–267. doi: 10.1038/bjc.1973.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Bluestein H. G., Zvaifler N. J. Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus. J Clin Invest. 1976 Feb;57(2):509–516. doi: 10.1172/JCI108303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Bock E., Hamberger A. Immunoelectrophoretic determination of brain-specific antigens in bulk-prepared neuronal and glial cells. Brain Res. 1976 Aug 13;112(2):329–335. doi: 10.1016/0006-8993(76)90287-0. [DOI] [PubMed] [Google Scholar]
  18. Bock E., Jorgensen O. S., Dittmann L., Eng L. F. Determination of brain-specific antigens in short term cultivated rat astroglial cells and in rat synaptosomes. J Neurochem. 1975 Dec;25(6):867–870. doi: 10.1111/j.1471-4159.1975.tb04419.x. [DOI] [PubMed] [Google Scholar]
  19. Bock E. Nervous system specific proteins. J Neurochem. 1978 Jan;30(1):7–14. doi: 10.1111/j.1471-4159.1978.tb07028.x. [DOI] [PubMed] [Google Scholar]
  20. Bogoch S. Astrocytin and malignin: two polypeptide fragments (recognins) related to brain tumor. Natl Cancer Inst Monogr. 1977 Dec;46:133–137. [PubMed] [Google Scholar]
  21. Bots G. T., Went L. N., Schaberg A. Results of a sedimentation technique for cytology of cerebrospinal fluid. Acta Cytol. 1964 May-Jun;8(3):234–241. [PubMed] [Google Scholar]
  22. Bradley N. J., Bloom H. J., Davies A. J., Swift S. M. Growth of human gliomas in immune-deficient mice: a possible model for pre-clinical therapy studies. Br J Cancer. 1978 Aug;38(2):263–272. doi: 10.1038/bjc.1978.197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Brett M., Weller R. O. Intracellular serum proteins in cerebral gliomas and metastatic tumours: an immunoperoxidase study. Neuropathol Appl Neurobiol. 1978 Jul-Aug;4(4):263–272. doi: 10.1111/j.1365-2990.1978.tb00544.x. [DOI] [PubMed] [Google Scholar]
  24. Brooks W. H., Caldwell H. D., Mortara R. H. Immune responses in patients with gliomas. Surg Neurol. 1974 Nov;2(6):419–423. [PubMed] [Google Scholar]
  25. Brooks W. H., Netsky M. G., Levine J. E. Immunity and tumors of the nervous system. Surg Neurol. 1975 Apr;3(4):184–186. [PubMed] [Google Scholar]
  26. Brooks W. H., Netsky M. G., Normansell D. E., Horwitz D. A. Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor. J Exp Med. 1972 Dec 1;136(6):1631–1647. doi: 10.1084/jem.136.6.1631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Brooks W. H., Roszman T. L., Rogers A. S. Impairment of rosette-forming T lymphocytes in patients with primary intracranial tumors. Cancer. 1976 Apr;37(4):1869–1873. doi: 10.1002/1097-0142(197604)37:4<1869::aid-cncr2820370435>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  28. Brouet J., Toben H. Characterization of a subpopulation of human T lymphocytes reactive with an heteroantiserum to human brain. J Immunol. 1976 Apr;116(4):1041–1044. [PubMed] [Google Scholar]
  29. Buckell M., Crompton M. R., Robertson M. C., Barnes G. K. Lactate dehydrogenase in cerebral cyst fluids; total activity and isoenzyme distributions as an index of malignancy. J Neurosurg. 1970 May;32(5):545–552. doi: 10.3171/jns.1970.32.5.0545. [DOI] [PubMed] [Google Scholar]
  30. Bush S. T., Swedlund H. A., Gleich G. J. Low molecular weight IgM in human sera. J Lab Clin Med. 1969 Feb;73(2):194–201. [PubMed] [Google Scholar]
  31. Böker D. K. Zur Immunfluoreszenz menschlicher Hirntumoren. Acta Neurochir (Wien) 1978;41(4):363–371. doi: 10.1007/BF01811349. [DOI] [PubMed] [Google Scholar]
  32. Campbell G. L., Schanchner M., Sharrow S. O. Isolation of glial cell-enriched and -depleted populations from mouse cerebellum by density gradient centrifugation and electronic cell sorting. Brain Res. 1977 May 20;127(1):69–86. doi: 10.1016/0006-8993(77)90380-8. [DOI] [PubMed] [Google Scholar]
  33. Carlsson J., Collins P., Brunk U. Plasma membrane motility and proliferation of human glioma cells in agarose and monolayer cultures. Acta Pathol Microbiol Scand A. 1978 Jan;86(1):45–55. doi: 10.1111/j.1699-0463.1978.tb02011.x. [DOI] [PubMed] [Google Scholar]
  34. Carson J. H., Barbarese E., Braun P. E., McPherson T. A. Components in multiple sclerosis cerebrospinal fluid that are detected by radioimmunoassay for myelin basic protein. Proc Natl Acad Sci U S A. 1978 Apr;75(4):1976–1978. doi: 10.1073/pnas.75.4.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Casper J. T., Borella L., Sen L. Reactivity of human brain antiserum with neuroblastoma cells and nonreactivity with thymocytes and lymphoblasts. Cancer Res. 1977 Jun;37(6):1750–1756. [PubMed] [Google Scholar]
  36. Catalano L. W., Jr, Harter D. H., Hsu K. C. Common antigen in meningioma-derived cell cultures. Science. 1972 Jan 14;175(4018):180–182. doi: 10.1126/science.175.4018.180. [DOI] [PubMed] [Google Scholar]
  37. Ciembroniewicz J., Kolar O. Tissue culture study of glioblastoma cells with addition of autologous lymphocytes. Acta Cytol. 1969 Jan;13(1):42–47. [PubMed] [Google Scholar]
  38. Coakham H. B., Lakshmi M. S. Tumour-associated surface antigen(s) in human astrocytomas. Oncology. 1975;31(3-4):234–243. [PubMed] [Google Scholar]
  39. Coakham H. Surface antigen(s) common to human astrocytoma cells. Nature. 1974 Jul 26;250(464):328–330. doi: 10.1038/250328a0. [DOI] [PubMed] [Google Scholar]
  40. Cuatico W., Cho J. R., Spiegelman S. Molecular evidence for a viral etiology of human CNS tumors. Acta Neurochir (Wien) 1976;35(1-3):149–160. doi: 10.1007/BF01405943. [DOI] [PubMed] [Google Scholar]
  41. Cuatico W., Woldron R., Jr, Tyschenko W. Biochemical evidence for viral-like characteristics in cerebrospinal fluids of brain tumor patients. Cancer. 1977 May;39(5):2240–2246. doi: 10.1002/1097-0142(197705)39:5<2240::aid-cncr2820390542>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  42. Cumberlin R. L., Luk K. H., Wara W. M., Sheline G. E., Wilson C. B. Medulloblastoma: treatment results and effect on normal tissues. Cancer. 1979 Mar;43(3):1014–1020. doi: 10.1002/1097-0142(197903)43:3<1014::aid-cncr2820430334>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  43. Dahl D., Bignami A. Glial fibrillary acidic protein from normal human brain. Purification and properties. Brain Res. 1973 Jul 27;57(2):343–360. doi: 10.1016/0006-8993(73)90141-8. [DOI] [PubMed] [Google Scholar]
  44. Deck J. H., Eng L. F., Bigbee J., Woodcock S. M. The role of glial fibrillary acidic protein in the diagnosis of central nervous system tumors. Acta Neuropathol. 1978 Jun 30;42(3):183–190. doi: 10.1007/BF00690355. [DOI] [PubMed] [Google Scholar]
  45. Delpech B., Buffe D. Etude immunochimique des extraits salins du cervau humain. Ann Inst Pasteur (Paris) 1972 Feb;122(2):331–340. [PubMed] [Google Scholar]
  46. Delpech B., Delpech A. Caracterisation immunochimique d'un antigene neuro-specifique, non specifique d'espece. Etude quantitative et localisation histologique chaz le rat. Immunochemistry. 1975 Aug;12(8):691–697. doi: 10.1016/0019-2791(75)90217-7. [DOI] [PubMed] [Google Scholar]
  47. Delpech B., Delpech A., Clément J., Laumonier R. Etude immunochimique et immunologique des tumeurs du cerveau humain. Int J Cancer. 1972 Mar 15;9(2):374–382. doi: 10.1002/ijc.2910090216. [DOI] [PubMed] [Google Scholar]
  48. Delpech B., Delpech A., Vidard M. N., Girard N., Tayot J., Clement J. C., Creissard P. Glial fibrillary acidic protein in tumours of the nervous system. Br J Cancer. 1978 Jan;37(1):33–40. doi: 10.1038/bjc.1978.5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Delpech B., Vidard M. N. Caracterisation immunochimique et immunohistologique d'une glycoproteine associee au systeme nerveux. Immunochemistry. 1976 Feb;13(2):111–116. doi: 10.1016/0019-2791(76)90277-9. [DOI] [PubMed] [Google Scholar]
  50. Delpech B., Vidard M. N., Schlosser M., Hernot C. Quelques propriétés d'une glycoprotéine antigeniquement spécifique du système nerveux. C R Seances Soc Biol Fil. 1973;167(6):1029–1032. [PubMed] [Google Scholar]
  51. Devesa S. S., Silverman D. T. Cancer incidence and mortality trends in the United States: 1935-74. J Natl Cancer Inst. 1978 Mar;60(3):545–571. doi: 10.1093/jnci/60.3.545. [DOI] [PubMed] [Google Scholar]
  52. Di Lorenzo N., Palma L., Nicole S. Lymphocytic infiltration in long-survival glioblastomas: possible host's resistance. Acta Neurochir (Wien) 1977;39(1-2):27–33. doi: 10.1007/BF01405238. [DOI] [PubMed] [Google Scholar]
  53. Diengdoh J. V., Booth A. E. Postirradiation necrosis of the temporal lobe presenting as a glioma. Case report. J Neurosurg. 1976 Jun;44(6):732–734. doi: 10.3171/jns.1976.44.6.0732. [DOI] [PubMed] [Google Scholar]
  54. Dittmann L., Axelsen N. H., Norgaard-Pedersen B., Bock E. Antigens in human glioblastomas and meningiomas: Search for tumour and onco-foetal antigens. Estimation of S-100 and GFA protein. Br J Cancer. 1977 Feb;35(2):135–141. doi: 10.1038/bjc.1977.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Dohan F. C., Jr, Kornblith P. L., Wellum G. R., Pfeiffer S. E., Levine L. S-100 protein and 2',3'-cyclic nucleotide 3'-phosphohydrolase in human brain tumors. Acta Neuropathol. 1977 Oct 10;40(2):123–128. doi: 10.1007/BF00688700. [DOI] [PubMed] [Google Scholar]
  56. Dolman C. L. Lymph node metastasis as first manifestation of glioblastoma. Case report. J Neurosurg. 1974 Nov;41(5):607–609. doi: 10.3171/jns.1974.41.5.0607. [DOI] [PubMed] [Google Scholar]
  57. Doria G., Baroni C. D. Cross-reactivity between human thymus and mouse lymphoid tissues, as revealed by rabbit antiserum against human brain. Proc Soc Exp Biol Med. 1975 Apr;148(4):1126–1131. doi: 10.3181/00379727-148-38702. [DOI] [PubMed] [Google Scholar]
  58. Dorling J., Kingston D., Webb J. A. Anti-streptococcal antibodies reacting with brain tissue. II. Utrastructural studies. Br J Exp Pathol. 1976 Jun;57(3):255–265. [PMC free article] [PubMed] [Google Scholar]
  59. Duffy P. E., Graf L., Rapport M. M. Identification of glial fibrillary acidic protein by the immunoperoxidase method in human brain tumors. J Neuropathol Exp Neurol. 1977 Jul;36(4):645–652. doi: 10.1097/00005072-197707000-00001. [DOI] [PubMed] [Google Scholar]
  60. Eggers A. E. Autoradiographic and fluorescence antibody studies of the human host immune response to gliomas. Neurology. 1972 Mar;22(3):246–250. doi: 10.1212/wnl.22.3.246. [DOI] [PubMed] [Google Scholar]
  61. Eng L. F., Rubinstein L. J. Contribution of immunohistochemistry to diagnostic problems of human cerebral tumors. J Histochem Cytochem. 1978 Jul;26(7):513–522. doi: 10.1177/26.7.357640. [DOI] [PubMed] [Google Scholar]
  62. Eng L. F., Vanderhaeghen J. J., Bignami A., Gerstl B. An acidic protein isolated from fibrous astrocytes. Brain Res. 1971 May 7;28(2):351–354. doi: 10.1016/0006-8993(71)90668-8. [DOI] [PubMed] [Google Scholar]
  63. Fairburn B., Urich H. Malignant gliomas occurring in identical twins. J Neurol Neurosurg Psychiatry. 1971 Dec;34(6):718–722. doi: 10.1136/jnnp.34.6.718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Febvre H., Maunoury R., Constans J. P., Trouillas P. Réactions d'hypersensibilité retardée avec des lignées de celluules tumorales humaines cultivées in vitro chez des malades porteurs de tumeurs cérébrales malignes. Int J Cancer. 1972 Jul 15;10(1):221–232. doi: 10.1002/ijc.2910100128. [DOI] [PubMed] [Google Scholar]
  65. Feldges A. J., Sartorius J., Niederer V. Beitrag zur ZNS-Tumordiagnostik mit Hilfe des zytozentrifugierten Liquors. Folia Haematol Int Mag Klin Morphol Blutforsch. 1978;105(3):342–353. [PubMed] [Google Scholar]
  66. Fewer D., Wilson C. B., Boldrey E. B., Enot K. J., Powell M. R. The chemotherapy of brain tumors. Clinical experience with carmustine (BCNU) and vincristine. JAMA. 1972 Oct 30;222(5):549–552. [PubMed] [Google Scholar]
  67. Fiori M., Di Mayorca G. Occurrence of BK virus DNA in DNA obtained from certain human tumors. Proc Natl Acad Sci U S A. 1976 Dec;73(12):4662–4666. doi: 10.1073/pnas.73.12.4662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Fumagalli R., Paoletti P. Sterol test for human brain tumors: relationship with different oncotypes. Neurology. 1971 Nov;21(11):1149–1156. doi: 10.1212/wnl.21.11.1149. [DOI] [PubMed] [Google Scholar]
  69. Furman M. A., Shulman K. Cyclic AMP and adenyl cyclase in brain tumors. J Neurosurg. 1977 Apr;46(4):477–483. doi: 10.3171/jns.1977.46.4.0477. [DOI] [PubMed] [Google Scholar]
  70. GARCIA J. H., OKAZAKI H., ARONSON S. M. BLOOD-GROUP FREQUENCIES AND ASTROCYTOMATA. J Neurosurg. 1963 May;20:397–399. doi: 10.3171/jns.1963.20.5.0397. [DOI] [PubMed] [Google Scholar]
  71. GREENE H. S. Heterotransplantation of tumors. Ann N Y Acad Sci. 1957 Dec 16;69(4):818–829. doi: 10.1111/j.1749-6632.1957.tb49720.x. [DOI] [PubMed] [Google Scholar]
  72. Garrett M. J., Hughes H. J., Freedman L. S. A comparison of radiotherapy alone with radiotherapy and CCNU in cerebral glioma. Clin Oncol. 1978 Mar;4(1):71–76. [PubMed] [Google Scholar]
  73. Glick M. C., Schlesinger H., Hummeler K. Glycopeptides from the surgace of human neuroblastoma cells. Cancer Res. 1976 Dec;36(12):4520–4524. [PubMed] [Google Scholar]
  74. Golub E. S. Brain-associated stem cell antigen: an antigen shared by brain and hemopoietic stem cells. J Exp Med. 1972 Aug 1;136(2):369–374. doi: 10.1084/jem.136.2.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Green J. R., Waggener J. D., Kriegsfeld B. A. Classification and incidence of neoplasms of the central nervous system. Adv Neurol. 1976;15:51–55. [PubMed] [Google Scholar]
  76. Greenlee J. E., Becker L. E., Narayan O., Johnson R. T. Failure to demonstrate papovavirus tumor antigen in human cerebral neoplasms. Ann Neurol. 1978 Jun;3(6):479–481. doi: 10.1002/ana.410030604. [DOI] [PubMed] [Google Scholar]
  77. Gregson N. A., Kennedy M., Leibowitz S. Gangliosides as surface antigens on cells isolated from the rat cerebellar cortex. Nature. 1977 Mar 31;266(5601):461–463. doi: 10.1038/266461a0. [DOI] [PubMed] [Google Scholar]
  78. Gupta R. K. Immunocytologic losses of isoantigens A, B, and H (O) in the endometrium and brain. Am J Clin Pathol. 1976 Aug;66(2):390–394. doi: 10.1093/ajcp/66.2.390. [DOI] [PubMed] [Google Scholar]
  79. HABEL K., BELCHER J. H. Immunologically privileged sites in studies of polyoma tumor antigens. Proc Soc Exp Biol Med. 1963 May;113:148–152. doi: 10.3181/00379727-113-28303. [DOI] [PubMed] [Google Scholar]
  80. Haglid K. G., Stavrou D., Rönnbäck L., Carlsson C. A., Weidenbach W. The S-100 protein in water-soluble and pentanol-extractable form in normal human brain and tumours of the human nervous system. A quantitative study. J Neurol Sci. 1973 Sep;20(1):103–111. doi: 10.1016/0022-510x(73)90122-6. [DOI] [PubMed] [Google Scholar]
  81. Haglid K. G., Stavrou D., Rönnbäck L., Carlsson C. A., Weidenbach W. The S-100 protein in water-soluble and pentanol-extractable form in normal human brain and tumours of the human nervous system. A quantitative study. J Neurol Sci. 1973 Sep;20(1):103–111. doi: 10.1016/0022-510x(73)90122-6. [DOI] [PubMed] [Google Scholar]
  82. Hass W. K. Soluble tissue antigens in human brain tumor and cerebrospinal fluid. Arch Neurol. 1966 Apr;14(4):443–447. doi: 10.1001/archneur.1966.00470100099013. [DOI] [PubMed] [Google Scholar]
  83. Heppner F., Möse J. R. The liquefaction (oncolysis) of malignant gliomas by a non pathogenic Clostridium. Acta Neurochir (Wien) 1978;42(1-2):123–125. doi: 10.1007/BF01406639. [DOI] [PubMed] [Google Scholar]
  84. Hersh E. M., Gutterman J. U., Mavligit G. M. Immunotherapy of human cancer. Adv Intern Med. 1977;22:145–185. [PubMed] [Google Scholar]
  85. Hitchcock M. H., Hollinshead A. C., Chretien P., Rizzoli H. V. Soluble membrane antigens of brain tumors. I. Controlled testing for cell-mediated immune responses in a long surviving glioblastoma multiforme patient. Cancer. 1977 Aug;40(2):660–666. doi: 10.1002/1097-0142(197708)40:2<660::aid-cncr2820400211>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  86. Hitchcock M. H., Hollinshead A. C., Chretien P., Rizzoli H. V. Soluble membrane antigens of brain tumors. I. Controlled testing for cell-mediated immune responses in a long surviving glioblastoma multiforme patient. Cancer. 1977 Aug;40(2):660–666. doi: 10.1002/1097-0142(197708)40:2<660::aid-cncr2820400211>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  87. Hopewell J. W., Edwards D. N., Wiernik G. Sex dependence of human intracranial gliomata. Br J Cancer. 1976 Dec;34(6):666–670. doi: 10.1038/bjc.1976.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Houck J. C., McBride H. J., O'Doherty D. S. The value of cerebrospinal fluid glycoprotein levels in the diagnosis of primary brain tumor. Neurology. 1968 Apr;18(4):397–402. doi: 10.1212/wnl.18.4.397. [DOI] [PubMed] [Google Scholar]
  89. Hydén H., McEwen B. A glial protein specific for the nervous system. Proc Natl Acad Sci U S A. 1966 Feb;55(2):354–358. doi: 10.1073/pnas.55.2.354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Hydén H., Rönnbäck L. Membrane-bound S-100 protein on nerve cells and its distribution. Brain Res. 1975 Dec 26;100(3):615–628. doi: 10.1016/0006-8993(75)90161-4. [DOI] [PubMed] [Google Scholar]
  91. Irie R. F., Irie K., Morton D. L. A membrane antigen common to human cancer and fetal brain tissues. Cancer Res. 1976 Sep;36(9 Pt 2):3510–3517. [PubMed] [Google Scholar]
  92. Isamat F., Miranda A. M., Bartumeus F., Prat J. Genetic implications of familial brain tumors. J Neurosurg. 1974 Nov;41(5):573–575. doi: 10.3171/jns.1974.41.5.0573. [DOI] [PubMed] [Google Scholar]
  93. Jacque C. M., Jorgensen O. S., Baumann N. A., Bock E. Brain-specific antigens in the Quaking mouse during ontogeny. J Neurochem. 1976 Oct;27(4):905–909. doi: 10.1111/j.1471-4159.1976.tb05153.x. [DOI] [PubMed] [Google Scholar]
  94. Jacque C. M., Kujas M., Poreau A., Raoul M., Collier P., Racadot J., Baumann N. GFA and S 100 protein levels as an index for malignancy in human gliomas and neurinomas. J Natl Cancer Inst. 1979 Mar;62(3):479–483. doi: 10.1093/jnci/62.3.479. [DOI] [PubMed] [Google Scholar]
  95. Jacque C. M., Vinner C., Kujas M., Raoul M., Racadot J., Baumann N. A. Determination of glial fibrillary acidic protein (GFAP) in human brain tumors. J Neurol Sci. 1978 Jan;35(1):147–155. doi: 10.1016/0022-510x(78)90107-7. [DOI] [PubMed] [Google Scholar]
  96. Jankovic B. D., Horvat J., Mitrovic K., Mostarica M. Antigenic determinants shared by rat lymphocytes and rat brain subcellular fractions. Keio J Med. 1975 Dec;24(4):355–365. doi: 10.2302/kjm.24.355. [DOI] [PubMed] [Google Scholar]
  97. Janković B. D., Horvat J., Mitrović K., Mostarica M. Rat brain-lymphocyte antigen: characterization by rabbit antisera to rat brain tubulin and S-100 protein. Immunochemistry. 1977 Jan;14(1):75–78. doi: 10.1016/0019-2791(77)90337-8. [DOI] [PubMed] [Google Scholar]
  98. Jellinger K., Denk H. Blood group isoantigens in angioblastic meningiomas and hemangioblastomas of the central nervous system. Virchows Arch A Pathol Anat Histol. 1974;364(2):137–144. doi: 10.1007/BF01240379. [DOI] [PubMed] [Google Scholar]
  99. Jellinger K. Glioblastoma multiforme: morphology and biology. Acta Neurochir (Wien) 1978;42(1-2):5–32. doi: 10.1007/BF01406628. [DOI] [PubMed] [Google Scholar]
  100. Jelsma R., Bucy P. C. The treatment of glioblastoma multiforme of the brain. J Neurosurg. 1967 Nov;27(5):388–400. doi: 10.3171/jns.1967.27.5.0388. [DOI] [PubMed] [Google Scholar]
  101. Jerry L. M., Lewis M. G., Rowden G., Sullivan A. K., Pitzele R., Law T. Fetal antigens in nonneoplastic conditions. Cancer Res. 1976 Sep;36(9 Pt 2):3446–3452. [PubMed] [Google Scholar]
  102. Kaufman H. H., Brisman R. Familial gliomas. Report of four cases. J Neurosurg. 1972 Jul;37(1):110–112. doi: 10.3171/jns.1972.37.1.0110. [DOI] [PubMed] [Google Scholar]
  103. Kehayov I. R. Tumour-associated water soluble antigen(s) in human glioblastoma demonstrated by immunodiffusion and immunoelectrophoresis. Ann Immunol (Paris) 1976 Sep-Oct;127(5):703–716. [PubMed] [Google Scholar]
  104. Kehayov I., Botev B., Vulchanov V., Kyurkchiev S. Demonstration of a phase (stage)-specific embryonic brain antigen in human meningioma. Int J Cancer. 1976 Nov 15;18(5):587–592. doi: 10.1002/ijc.2910180507. [DOI] [PubMed] [Google Scholar]
  105. Kingston D., Glynn L. E. Anti-streptococcal antibodies reacting with brain tissue. I. Immunofluourescent studies. Br J Exp Pathol. 1976 Feb;57(1):114–128. [PMC free article] [PubMed] [Google Scholar]
  106. Kornblith P. L., Dohan F. C., Jr, Wood W. C., Whitman B. O. Human astrocytoma: serum-mediated immunologic response. Cancer. 1974 Jun;33(6):1512–1519. doi: 10.1002/1097-0142(197406)33:6<1512::aid-cncr2820330607>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  107. Krishnan K. S., Balaram P. Mammalian brain plasma membranes. Isolation, enzymatic, and chemical characterization. Exp Cell Res. 1976 Sep;101(2):299–306. doi: 10.1016/0014-4827(76)90381-5. [DOI] [PubMed] [Google Scholar]
  108. Kumar S., Taylor G., Steward J. K., Waghe M. A., Morris-Jones P. Cell-mediated immunity and blocking factors in patients with tumours of the central nervous system. Int J Cancer. 1973 Jul 15;12(1):194–205. doi: 10.1002/ijc.2910120120. [DOI] [PubMed] [Google Scholar]
  109. Levin V. A., Hoffman W. F., Pischer T. L., Seager M. L., Boldrey E. B., Wilson C. B. BCNU-5-fluorouracil combination therapy for recurrent malignant brain tumors. Cancer Treat Rep. 1978 Dec;62(12):2071–2076. [PubMed] [Google Scholar]
  110. Levy N. L. Cell-mediated cytotoxicity and serum-mediated blocking: evidence that their associated determinants on human tumor cells are different. J Immunol. 1978 Sep;121(3):916–922. [PubMed] [Google Scholar]
  111. Levy N. L. Specificity of lymphocyte-mediated cytotoxicity in patients with primary intracranial tumors. J Immunol. 1978 Sep;121(3):903–915. [PubMed] [Google Scholar]
  112. Liao C. L., Eng L. F., Herman M. M., Bensch K. G. Glial fibrillary acidic protein-solubility characteristics, relation to cell growth phases and cellular localization in rat C-6 glioma cells: an immunoradiometric and immunohistologic study. J Neurochem. 1978 May;30(5):1181–1186. doi: 10.1111/j.1471-4159.1978.tb12415.x. [DOI] [PubMed] [Google Scholar]
  113. Lisak R. P., Abramsky O., Dorfman S. H., George J., Manning M. C., Pleasure D. E., Saida T., Silberberg D. H. Antibodies to galactocerebroside bind to oligodendroglia in suspension culture. J Neurol Sci. 1979 Jan;40(1):65–73. doi: 10.1016/0022-510x(79)90009-1. [DOI] [PubMed] [Google Scholar]
  114. Long J. C., Aisenberg A. C., Zamecnik P. C. Chromatographic and electrophoretic analysis of an antigen in Hodgkin's disease tissue cultures. J Natl Cancer Inst. 1977 Feb;58(2):223–227. doi: 10.1093/jnci/58.2.223. [DOI] [PubMed] [Google Scholar]
  115. Lyampert I. M., Danilova T. A. Immunological phenomena associated with cross-reactive antigens of micro-organisms and mammalian tissues. Prog Allergy. 1975;18:423–477. [PubMed] [Google Scholar]
  116. Lynch H. T., Guirgis H. A. Childhood cancer and the SBLA syndrome. Med Hypotheses. 1979 Jan;5(1):15–22. doi: 10.1016/0306-9877(79)90059-8. [DOI] [PubMed] [Google Scholar]
  117. Lynch H. T., Mulcahy G. M., Harris R. E., Guirgis H. A., Lynch J. F. Genetic and pathologic findings in a kindred with hereditary sarcoma, breast cancer, brain tumors, leukemia, lung, laryngeal, and adrenal cortical carcinoma. Cancer. 1978 May;41(5):2055–2064. doi: 10.1002/1097-0142(197805)41:5<2055::aid-cncr2820410554>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  118. MORLEY T. P. The recovery of tumour cells from venous blood draining cerebral gliomas; a preliminary report. Can J Surg. 1959 Jul;2(4):363–365. [PubMed] [Google Scholar]
  119. Mahaley M. S., Jr, Brooks W. H., Roszman T. L., Bigner D. D., Dudka L., Richardson S. Immunobiology of primary intracranial tumors. Part 1: studies of the cellular and humoral general immune competence of brain-tumor patients. J Neurosurg. 1977 Apr;46(4):467–476. doi: 10.3171/jns.1977.46.4.0467. [DOI] [PubMed] [Google Scholar]
  120. Mahaley M. S., Jr, Day E. D. Immunological studies of human gliomas. J Neurosurg. 1965 Oct;23(4):363–370. doi: 10.3171/jns.1965.23.4.0363. [DOI] [PubMed] [Google Scholar]
  121. Mahaley M. S., Jr Experiences with antibody production from human glioma tissue. Prog Exp Tumor Res. 1972;17:31–39. doi: 10.1159/000393666. [DOI] [PubMed] [Google Scholar]
  122. Maltoni C., Lefemine G. Carcinogenicity bioassays of vinyl chloride: current results. Ann N Y Acad Sci. 1975 Jan 31;246:195–218. doi: 10.1111/j.1749-6632.1975.tb51094.x. [DOI] [PubMed] [Google Scholar]
  123. Manasek F. J., Cohen A. M. Anionic glycopeptides and glycosaminoglycans synthesized by embryonic neural tube and neural crest. Proc Natl Acad Sci U S A. 1977 Mar;74(3):1057–1061. doi: 10.1073/pnas.74.3.1057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Manuelidis L., Manuelidis E. E. Amount of satellite DNA in four experimentally induced tumors of the central nervous system. Quantitative changes in a glioblastoma producing C-type particles. J Natl Cancer Inst. 1976 Jan;56(1):43–50. doi: 10.1093/jnci/56.1.43. [DOI] [PubMed] [Google Scholar]
  125. Martin-Achard A., Diserens A. C., de Tribolet N., Zander E., Carrel S. Recherche danticorps anti-tumeur dans les sérums de malades atteints de gliomes. Schweiz Med Wochenschr. 1978 Jun 24;108(25):959–962. [PubMed] [Google Scholar]
  126. Martin S. E., Martin W. J. Interspecies brain antigen detected by naturally occurring mouse anti-brain autoantibody. Proc Natl Acad Sci U S A. 1975 Mar;72(3):1036–1040. doi: 10.1073/pnas.72.3.1036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Marton L. J., Edwards M. S., Levin V. A., Lubich W. P., Wilson C. B. Predictive value of cerebrospinal fluid polyamines in medulloblastoma. Cancer Res. 1979 Mar;39(3):993–997. [PubMed] [Google Scholar]
  128. Martuza R. L., Shamberger R. C., Phillips J. P., Kornblith P. L., Dohan F. C., Jr, Hochberg F. H. A lymphocyte-dependent antibody assay for detection of antibodies to human glioma cells. Surg Forum. 1975;26:492–494. [PubMed] [Google Scholar]
  129. Maznina T. P., Kushner S. G. Studies on human brain-thymus cross-reactive antigens. J Immunol. 1976 Sep;117(3):818–821. [PubMed] [Google Scholar]
  130. McDermott J. R., Smith A. R. Absence of myelin basic protein from glial cell lines and cultures. J Neurochem. 1978 Jun;30(6):1637–1639. doi: 10.1111/j.1471-4159.1978.tb10511.x. [DOI] [PubMed] [Google Scholar]
  131. Michetti F., Miani N., De Renzis G., Caniglia A., Correr S. Nuclear localization of S-100 protein. J Neurochem. 1974 Feb;22(2):239–244. doi: 10.1111/j.1471-4159.1974.tb11585.x. [DOI] [PubMed] [Google Scholar]
  132. Miki Y., Sano K., Takakura K., Mizutani H. [Adjuvant immunotherapy with BCG for malignant brain tumors (author's transl)]. Neurol Med Chir (Tokyo) 1976 Jul;16(4 Pt 2):357–364. doi: 10.2176/nmc.16pt2.357. [DOI] [PubMed] [Google Scholar]
  133. Miyake E., Kitamura K., Nomoto K., Takeya K. An attempt to detect cell surface antigens in cultured human brain tumors by mixed hemadsorption test. First report. Acta Neuropathol. 1977 Jan 31;37(1):27–29. doi: 10.1007/BF00684536. [DOI] [PubMed] [Google Scholar]
  134. Moore B. W. A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun. 1965 Jun 9;19(6):739–744. doi: 10.1016/0006-291x(65)90320-7. [DOI] [PubMed] [Google Scholar]
  135. Morantz R. A., Shain W., Cravioto H. Immune surveillance and tumors of the nervous system. J Neurosurg. 1978 Jul;49(1):84–92. doi: 10.3171/jns.1978.49.1.0084. [DOI] [PubMed] [Google Scholar]
  136. Mori T., Morimoto K., Hayakawa T., Ushio Y., Mogami H., Sekiguchi K. Radioimmunoassay of astroprotein (an astrocyte-specific cerebroprotein) in cerebrospinal fluid and its clinical significance. Neurol Med Chir (Tokyo) 1978;18(1 Pt 1):25–31. doi: 10.2176/nmc.18pt1.25. [DOI] [PubMed] [Google Scholar]
  137. Morton D. L. Cancer immunotherapy: an overview. Semin Oncol. 1974 Dec;1(4):297–310. [PubMed] [Google Scholar]
  138. Murray J. L., Axtell L. M. Editorial: Impact of Cancer: years of life lost due to cancer mortality. J Natl Cancer Inst. 1974 Jan;52(1):3–7. doi: 10.1093/jnci/52.1.3. [DOI] [PubMed] [Google Scholar]
  139. Murray K. J., Kay N. E., Douglas S. D. Blood-group antigens and antibodies in human brain-tumor cysts. J Neurosurg. 1978 Feb;48(2):164–168. doi: 10.3171/jns.1978.48.2.0164. [DOI] [PubMed] [Google Scholar]
  140. Nakagaki H., Brunhart G., Kemper T. L., Caveness W. F. Monkey brain damage from radiation in the therapeutic range. J Neurosurg. 1976 Jan;44(1):3–11. doi: 10.3171/jns.1976.44.1.0003. [DOI] [PubMed] [Google Scholar]
  141. Narayan O., Penney J. B., Jr, Johnson R. T., Herndon R. M., Weiner L. P. Etiology of progressive multifocal leukoencephalopathy. Identification of papovavirus. N Engl J Med. 1973 Dec 13;289(24):1278–1282. doi: 10.1056/NEJM197312132892405. [DOI] [PubMed] [Google Scholar]
  142. Narayan O., Weiner L. P. Biological properties of two strains of Simian virus 40 isolated from patients with progressive multifocal leukoencephalopathy. Infect Immun. 1974 Jul;10(1):173–179. doi: 10.1128/iai.10.1.173-179.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  143. Neuwelt E. A., Clark K., Kirkpatrick J. B., Toben H. Clinical studies of intrathecal autologous lymphocyte infusions in patients with malignant glioma: a toxicity study. Ann Neurol. 1978 Oct;4(4):307–312. doi: 10.1002/ana.410040404. [DOI] [PubMed] [Google Scholar]
  144. Nielsen H. E., Koch C. Genetic control of the in vitro responses of rat blood lymphocytes. I. Comparison of in vitro and in vivo responses. Scand J Immunol. 1975;4(1):31–36. doi: 10.1111/j.1365-3083.1975.tb02597.x. [DOI] [PubMed] [Google Scholar]
  145. Ommaya A. K. Immunotherapy of gliomas: a review. Adv Neurol. 1976;15:337–359. [PubMed] [Google Scholar]
  146. PATERSON P. Y. Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J Exp Med. 1960 Jan 1;111:119–136. doi: 10.1084/jem.111.1.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Packman P. M., Blomstrand C., Hamberger A. Disc electrophoretic separation of proteins in neuronal, glial and subcellular fractions from cerebral cortex. J Neurochem. 1971 Mar;18(3):479–487. doi: 10.1111/j.1471-4159.1971.tb11975.x. [DOI] [PubMed] [Google Scholar]
  148. Padgett B. L., Walker D. L. Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. J Infect Dis. 1973 Apr;127(4):467–470. doi: 10.1093/infdis/127.4.467. [DOI] [PubMed] [Google Scholar]
  149. Padgett B. L., Walker D. L., ZuRhein G. M., Hodach A. E., Chou S. M. JC Papovavirus in progressive multifocal leukoencephalopathy. J Infect Dis. 1976 Jun;133(6):686–690. doi: 10.1093/infdis/133.6.686. [DOI] [PubMed] [Google Scholar]
  150. Palma L., Di Lorenzo N., Guidetti B. Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases. J Neurosurg. 1978 Dec;49(6):854–861. doi: 10.3171/jns.1978.49.6.0854. [DOI] [PubMed] [Google Scholar]
  151. Paoletti P., Fumagalli R., Weiss J. F., Pezzotta S. Desmosterol: a biochemical marker of glioma growth. Surg Neurol. 1977 Dec;8(6):399–405. [PubMed] [Google Scholar]
  152. Pasquier B., Pasquier D., Lachard A., N'Golet A., Panh M. H., Couderc P. Les métastases extranevraxiques des tumeurs du système nerveux central. Bull Cancer. 1979;66(1):25–28. [PubMed] [Google Scholar]
  153. Perria C., Di Benedetto G., Barabino A., Soldà A. M., Indiveri F. Valutazione dello stato immunitario in pazienti affetti da neoplasia cerebrale. Boll Soc Ital Biol Sper. 1974 Nov 30;50(22):1930–1935. [PubMed] [Google Scholar]
  154. Pfreundschuh M., Shiku H., Takahashi T., Ueda R., Ransohoff J., Oettgen H. F., Old L. J. Serological analysis of cell surface antigens of malignant human brain tumors. Proc Natl Acad Sci U S A. 1978 Oct;75(10):5122–5126. doi: 10.1073/pnas.75.10.5122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  155. Phillips J. P., Sujatanond M., Martuza R. L., Quindlen E. A., Wood W. C., Kornblith P. L., Dohan F. C., Jr Cytotoxic antibodies in preoperative glioma patients: a diagnostic assay. Acta Neurochir (Wien) 1976;35(1-3):43–52. doi: 10.1007/BF01405931. [DOI] [PubMed] [Google Scholar]
  156. Pilch Y. H., Myers G. H., Sparks F. C., Golub S. H. Prospects for the immunotherapy of cancer. Part II: current status of immunotherapy. Curr Probl Surg. 1975 Feb;:1–61. [PubMed] [Google Scholar]
  157. Poduslo S. E., McFarland H. F., McKhann G. M. Antiserums to neurons and to oligodendroglia from mammalian brain. Science. 1977 Jul 15;197(4300):270–272. doi: 10.1126/science.327546. [DOI] [PubMed] [Google Scholar]
  158. Pontén J., Macintyre E. H. Long term culture of normal and neoplastic human glia. Acta Pathol Microbiol Scand. 1968;74(4):465–486. doi: 10.1111/j.1699-0463.1968.tb03502.x. [DOI] [PubMed] [Google Scholar]
  159. Popova G. M. Tserebrozidy gliom mozga cheloveka. Vopr Med Khim. 1978 Mar-Apr;24(2):169–171. [PubMed] [Google Scholar]
  160. Preissig S. H., Bohmfalk G. L., Reichel G. W., Smith M. T. Anaplastic astrocytoma following radiation for a glomus jugular tumor. Cancer. 1979 Jun;43(6):2243–2247. doi: 10.1002/1097-0142(197906)43:6<2243::aid-cncr2820430614>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  161. Quindlen E. A., Dohan F. C., Jr, Kornblith P. L. Improved assay for cytotoxic antiglioma antibody. Surg Forum. 1974;25(0):464–466. [PubMed] [Google Scholar]
  162. REIF A. E., ALLEN J. M. THE AKR THYMIC ANTIGEN AND ITS DISTRIBUTION IN LEUKEMIAS AND NERVOUS TISSUES. J Exp Med. 1964 Sep 1;120:413–433. doi: 10.1084/jem.120.3.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  163. RICHARDSON E. P., Jr Progressive multifocal leukoencephalopathy. N Engl J Med. 1961 Oct 26;265:815–823. doi: 10.1056/NEJM196110262651701. [DOI] [PubMed] [Google Scholar]
  164. Raff M. C., Mirsky R., Fields K. L., Lisak R. P., Dorfman S. H., Silberberg D. H., Gregson N. A., Leibowitz S., Kennedy M. C. Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in culture. Nature. 1978 Aug 24;274(5673):813–816. [PubMed] [Google Scholar]
  165. Reagan T. J., Bisel H. F., Childs D. S., Jr, Layton D. D., Rhoton A. L., Jr, Taylor W. F. Controlled study of CCNU and radiation therapy in malignant astrocytoma. J Neurosurg. 1976 Feb;44(2):186–190. doi: 10.3171/jns.1976.44.2.0186. [DOI] [PubMed] [Google Scholar]
  166. Richter-Landsberg C., Yavin E. Protein profiles of rat embryo cerebral cells during differentiation in culture. J Neurochem. 1979 Jan;32(1):133–143. doi: 10.1111/j.1471-4159.1979.tb04520.x. [DOI] [PubMed] [Google Scholar]
  167. Ridley A. Antilymphocytic serum and tumour transplantation in the brain. Acta Neuropathol. 1971;19(4):307–317. doi: 10.1007/BF00692151. [DOI] [PubMed] [Google Scholar]
  168. Ridley A., Cavanagh J. B. Lymphocytic infiltration in gliomas: evidence of possible host resistance. Brain. 1971;94(1):117–124. doi: 10.1093/brain/94.1.117. [DOI] [PubMed] [Google Scholar]
  169. Ridley A., Cavanagh J. B. The cellular reactions to heterologous, homologous and autologous skin implanted into brain. J Pathol. 1969 Nov;99(3):193–203. doi: 10.1002/path.1710990303. [DOI] [PubMed] [Google Scholar]
  170. Ridley A. Immunological aspects of gliomas. Proc R Soc Med. 1977 Dec;70(12):867–869. [PMC free article] [PubMed] [Google Scholar]
  171. Ridley A. Survival of guinea pig skin grafts in the brains of rats under treatment with antilymphocytic serum. Transplantation. 1970 Jul;10(1):86–91. doi: 10.1097/00007890-197007000-00009. [DOI] [PubMed] [Google Scholar]
  172. Ridley A. The effect of cyclophosphamide and antilymphocytic serum on the cellular reactions to homologous skin implanted into brain. Acta Neuropathol. 1970;15(4):351–358. doi: 10.1007/BF00684732. [DOI] [PubMed] [Google Scholar]
  173. Rusca G., Calissano P., Alema S. Identification of a membrane bound fraction of the S-100 protein. Brain Res. 1973 Jan 15;49(1):223–227. doi: 10.1016/0006-8993(73)90419-8. [DOI] [PubMed] [Google Scholar]
  174. SCHEINBERG L. C., EDELMAN F. L., LEVY W. A. IS THE BRAIN "AN IMMUNOLOGICALLY PRIVILEGED SITE"?I. STUDIES BASED ON INTRACEREBRAL TUMOR HOMOTRANSPLANTATION AND ISOTRANSPLANTATION TO SENSITIZED HOSTS. Arch Neurol. 1964 Sep;11:248–264. doi: 10.1001/archneur.1964.00460210026003. [DOI] [PubMed] [Google Scholar]
  175. SCHEINBERG L. C., SUZUKI K., EDELMAN F., DAVIDOFF L. M. STUDIES IN IMMUNIZATION AGAINST A TRANSPLANTABLE CEREBRAL MOUSE GLIOMA. J Neurosurg. 1963 Apr;20:312–317. doi: 10.3171/jns.1963.20.4.0312. [DOI] [PubMed] [Google Scholar]
  176. SCHURR P. H., MCLAURIN R. L., INGRAHAM F. D. Experimental studies on the circulation of the cerebrospinal fluid and methods of producing communicating hydrocephalus in the dog. J Neurosurg. 1953 Sep;10(5):515–525. doi: 10.3171/jns.1953.10.5.0515. [DOI] [PubMed] [Google Scholar]
  177. SELVERSTONE B., COOPER D. R. Astrocytomas and ABO blood groups. J Neurosurg. 1961 Sep;18:602–604. doi: 10.3171/jns.1961.18.5.0602. [DOI] [PubMed] [Google Scholar]
  178. Santana V., Turk J. L. Binding of heterologous anti-brain antibodies to mouse B cells. Immunology. 1976 Jun;30(6):859–864. [PMC free article] [PubMed] [Google Scholar]
  179. Sato K., Raimondi A. J., Dray S., Molinaro G. A. Comparison of tumor-associated surface antigens on cells from medulloblastomas and from other neoplasms of the human nervous system. Childs Brain. 1978;4(2):83–94. doi: 10.1159/000119764. [DOI] [PubMed] [Google Scholar]
  180. Sayk J., Olischer R. M. Fortschritte der Liquorzytologie bei der Diagnostik bösartiger Hirngeschwülste (3. Mitteilung) Psychiatr Neurol Med Psychol (Leipz) 1967 Mar;19(3):88–99. [PubMed] [Google Scholar]
  181. Schachner M., Wortham K. A., Ruberg M. Z., Dorfman S., Campbell G. L. Brain cell surface antigens detected by anti-corpus callosum antiserum. Brain Res. 1977 May 20;127(1):87–97. doi: 10.1016/0006-8993(77)90381-x. [DOI] [PubMed] [Google Scholar]
  182. Scheinberg L. C., Kotsilimbas D. G., Karpf R., Mayer N. Is the brain "an immunologically privileged site"? 3. Studies based on homologous skin grafts to the brain and subcutaneous tissues. Arch Neurol. 1966 Jul;15(1):62–67. doi: 10.1001/archneur.1966.00470130066006. [DOI] [PubMed] [Google Scholar]
  183. Scheinberg L. C., Levy A., Edelman F. Is the brain an "immunologically privileged site"? 2. Studies in induced host resistance to transplantable mouse glioma following irradiation of prior implants. Arch Neurol. 1965 Sep;13(3):283–286. doi: 10.1001/archneur.1965.00470030063005. [DOI] [PubMed] [Google Scholar]
  184. Schliep G., Felgenhauer K. Serum-CSF protein gradients, the blood-GSF barrier and the local immune response. J Neurol. 1978 May 18;218(2):77–96. doi: 10.1007/BF02402169. [DOI] [PubMed] [Google Scholar]
  185. Schmechel D., Marangos P. J., Zis A. P., Brightman M., Goodwin F. K. Brain endolases as specific markers of neuronal and glial cells. Science. 1978 Jan 20;199(4326):313–315. doi: 10.1126/science.339349. [DOI] [PubMed] [Google Scholar]
  186. Schneck S. A., Penn I. De-novo brain tumours in renal-transplant recipients. Lancet. 1971 May 15;1(7707):983–986. doi: 10.1016/s0140-6736(71)91384-5. [DOI] [PubMed] [Google Scholar]
  187. Schoenberg B. S., Christine B. W., Whisnant J. P. The resolution of discrepancies in the reported incidence of primary brain tumors. Neurology. 1978 Aug;28(8):817–823. doi: 10.1212/wnl.28.8.817. [DOI] [PubMed] [Google Scholar]
  188. Seidenfeld J., Marton L. J. Biochemical markers of central nervous system tumors in cerebrospinal fluid. Ann Clin Lab Sci. 1978 Nov-Dec;8(6):459–466. [PubMed] [Google Scholar]
  189. Selker R. G., Wolmark N., Fisher B., Moore P. Preliminary observations on the use of Corynebacterium parvum in patients with primary intracranial tumors: effect on intracranial pressure. J Surg Oncol. 1978;10(4):299–303. doi: 10.1002/jso.2930100404. [DOI] [PubMed] [Google Scholar]
  190. Sheikh K. M., Apuzzo M. L., Kochsiek K. R., Weiss M. H. Malignant glial neoplasms: definition of a humoral host response to tumor-associated antigen(s). Yale J Biol Med. 1977 Jul-Aug;50(4):397–403. [PMC free article] [PubMed] [Google Scholar]
  191. Sheikh K. M., Apuzzo M. L., Weiss M. H. Specific cellular immune responses in patients with malignant gliomas. Cancer Res. 1979 May;39(5):1733–1738. [PubMed] [Google Scholar]
  192. Sheline G. E. Radiation therapy of brain tumors. Cancer. 1977 Feb;39(2 Suppl):873–881. doi: 10.1002/1097-0142(197702)39:2+<873::aid-cncr2820390725>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  193. Shimizu T., Kito K., Yamazaki N., Kubo O., Kitamura K. [Immunological investigation of brain tumor patients (author's transl)]. Neurol Med Chir (Tokyo) 1976 Jul;16(4 Pt 2):337–347. doi: 10.2176/nmc.16pt2.337. [DOI] [PubMed] [Google Scholar]
  194. Shuttleworth E. C., Jr Barrier phenomena in brain tumors. Prog Exp Tumor Res. 1972;17:279–290. doi: 10.1159/000393677. [DOI] [PubMed] [Google Scholar]
  195. Silverberg E. Cancer statistics, 1978. CA Cancer J Clin. 1978 Jan-Feb;28(1):17–32. doi: 10.3322/canjclin.28.1.17. [DOI] [PubMed] [Google Scholar]
  196. Sogg R. L., Donaldson S. S., Yorke C. H. Malignant astrocytoma following radiotherapy of a craniopharyngoima. Case report. J Neurosurg. 1978 Apr;48(4):622–627. doi: 10.3171/jns.1978.48.4.0622. [DOI] [PubMed] [Google Scholar]
  197. Solheid C., Lauro G., Palladini G. Two separate membrane-bound antigens on human glioma cells in tissue culture detected with sera from glioma patients by immunofluorescence. J Neurol Sci. 1976 Nov;30(1):55–64. doi: 10.1016/0022-510x(76)90255-0. [DOI] [PubMed] [Google Scholar]
  198. Stallcup W. B., Cohn M. Correlation of surface antigens and cell type in cloned cell lines from the rat central nervous system. Exp Cell Res. 1976 Mar 15;98(2):285–297. doi: 10.1016/0014-4827(76)90440-7. [DOI] [PubMed] [Google Scholar]
  199. Stratton J. A., Byfield P. E. Reactions of anti-human brain serum with human lymphocyte subpopulations. Cell Immunol. 1977 Jan;28(1):1–14. doi: 10.1016/s0008-8749(77)80001-4. [DOI] [PubMed] [Google Scholar]
  200. Tabuchi K., Kirsch W. M. Detection of IgG on glioblastoma cell surface in vivo. Acta Neurochir (Wien) 1978;43(1-2):93–100. doi: 10.1007/BF01809228. [DOI] [PubMed] [Google Scholar]
  201. Takada A., Takada Y., Ito U., Minowada J. Shared antigenic determinants between human brain and human T-cell line. Clin Exp Immunol. 1974 Dec;18(4):491–498. [PMC free article] [PubMed] [Google Scholar]
  202. Takakura K., Miki Y., Kubo O. Adjuvant immunotherapy for malignant brain tumors in infants and children. Childs Brain. 1975;1(2-3):141–147. doi: 10.1159/000119563. [DOI] [PubMed] [Google Scholar]
  203. Takeuchi J., Barnard R. O. Perivascular lymphocytic cuffing in astrocytomas. Acta Neuropathol. 1976;35(3):265–271. [PubMed] [Google Scholar]
  204. Thomas D. B. Proceedings: Expression of surface antigens in relation to the mitotic cell cycle. Br J Cancer. 1975 Aug;32(2):283–284. doi: 10.1038/bjc.1975.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  205. Thomas D. G., Lannigan C. B., Behan P. O. Letter: Impaired cell-mediated immunity in human brain tumours. Lancet. 1975 Jun 21;1(7921):1389–1390. doi: 10.1016/s0140-6736(75)92308-9. [DOI] [PubMed] [Google Scholar]
  206. Toh B. H., Muller H. K., Elrick W. L. Smooth muscle associated antigen in astrocytes and astrocytomata. Br J Cancer. 1976 Feb;33(2):195–202. doi: 10.1038/bjc.1976.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  207. Tokumaru T., Catalano L. W. Elevation of serum immunoglobulin M (IgM) level in patients with brain tumors. Surg Neurol. 1975 Jul;4(1):17–21. [PubMed] [Google Scholar]
  208. Trouillas P. Immunologie des tumeurs cérébrales: l'antigène carcino-foetal glial. Ann Inst Pasteur (Paris) 1972 Apr;122(4):819–828. [PubMed] [Google Scholar]
  209. Trouillas P. Immunologie et immunothérapie des tumeurs cérébrales. Etat actuel. Rev Neurol (Paris) 1973 Jan;128(1):23–38. [PubMed] [Google Scholar]
  210. Uyeda C. T., Eng L. F., Bignami A. Immunological study of the glial fibrillary acidic protein. Brain Res. 1972 Feb 11;37(1):81–89. doi: 10.1016/0006-8993(72)90347-2. [DOI] [PubMed] [Google Scholar]
  211. Vaheri A., Ruoslahti E., Westermark B., Ponten J. A common cell-type specific surface antigen in cultured human glial cells and fibroblasts: loss in malignant cells. J Exp Med. 1976 Jan 1;143(1):64–72. doi: 10.1084/jem.143.1.64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  212. Vidard M. N., Girard N., Chauzy C., Delpech B., Delpech A., Maunoury R., Laumonier R. Disparition de la protéine gliofibrillaire (GFA) au cours de la culture de cellules de glioblastomes. C R Acad Sci Hebd Seances Acad Sci D. 1978 Jun 19;286(24):1837–1840. [PubMed] [Google Scholar]
  213. Wahlström T., Linder E., Saksela E., Westermark B. Tumor-specific membrane antigens in established cell lines from gliomas. Cancer. 1974 Aug;34(2):274–279. doi: 10.1002/1097-0142(197408)34:2<274::aid-cncr2820340209>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  214. Wahlström T., Saksela E., Troupp H. Cell-bound antiglial immunity in patients with malignant tumors of the brain. Cell Immunol. 1973 Feb;6(2):161–170. doi: 10.1016/0008-8749(73)90019-1. [DOI] [PubMed] [Google Scholar]
  215. Walker M. D., Alexander E., Jr, Hunt W. E., MacCarty C. S., Mahaley M. S., Jr, Mealey J., Jr, Norrell H. A., Owens G., Ransohoff J., Wilson C. B. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg. 1978 Sep;49(3):333–343. doi: 10.3171/jns.1978.49.3.0333. [DOI] [PubMed] [Google Scholar]
  216. Walker M. D. Malignant brain tumors - a synopsis. CA Cancer J Clin. 1975 May-Jun;25(3):114–120. doi: 10.3322/canjclin.25.3.114. [DOI] [PubMed] [Google Scholar]
  217. Warecka K. Immunological differential diagnosis of human brain tumours. J Neurol Sci. 1975 Dec;26(4):511–516. doi: 10.1016/0022-510x(75)90052-0. [DOI] [PubMed] [Google Scholar]
  218. Warecka K. Immunological differential diagnosis of human brain tumours. J Neurol Sci. 1975 Dec;26(4):511–516. doi: 10.1016/0022-510x(75)90052-0. [DOI] [PubMed] [Google Scholar]
  219. Warecka K., Möller H. J., Vogel H. M., Tripatzis I. Human brain-specific alpha 2 -glycoprotein: purification by affinity chromatography and detection of a new component; localization in nervous cells. J Neurochem. 1972 Mar;19(3):719–725. doi: 10.1111/j.1471-4159.1972.tb01387.x. [DOI] [PubMed] [Google Scholar]
  220. Warecka K., Müller D. The appearance of human "brain-specific" glycoprotein in ontogenesis. J Neurol Sci. 1969 Mar-Apr;8(2):329–345. doi: 10.1016/0022-510x(69)90116-6. [DOI] [PubMed] [Google Scholar]
  221. Waxweiler R. J., Stringer W., Wagoner J. K., Jones J., Falk H., Carter C. Neoplastic risk among workers exposed to vinyl chloride. Ann N Y Acad Sci. 1976;271:40–48. doi: 10.1111/j.1749-6632.1976.tb23091.x. [DOI] [PubMed] [Google Scholar]
  222. Weir B., Band P., Urtasun R., Blain G., Mclean D., Wilson F., Mielke B., Grace M. Radiotherapy and CCNU in the treatment of high-grade supratentorial astrocytomas. J Neurosurg. 1976 Aug;45(2):129–134. doi: 10.3171/jns.1976.45.2.0129. [DOI] [PubMed] [Google Scholar]
  223. Weiss A. F., Portmann R., Fischer H., Simon J., Zang K. D. Simian virus 40-related antigens in three human meningiomas with defined chromosome loss. Proc Natl Acad Sci U S A. 1975 Feb;72(2):609–613. doi: 10.1073/pnas.72.2.609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  224. Weiss J. F., Morantz R. A., Bradley W. P., Chretien P. B. Serum acute-phase proteins and immunoglobulins in patients with gliomas. Cancer Res. 1979 Feb;39(2 Pt 1):542–544. [PubMed] [Google Scholar]
  225. Whiteside T. L. Reactivity of anti-human brain serum with human lymphocytes. Am J Pathol. 1977 Jan;86(1):1–16. [PMC free article] [PubMed] [Google Scholar]
  226. Wickremesinghe H. R., Yates P. O. Immunological properties of neoplastic neural tissues. Br J Cancer. 1971 Dec;25(4):711–720. doi: 10.1038/bjc.1971.86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  227. Wikstrand C. J., Bigner D. D. Surface antigens of human glioma cells shared with normal adult and fetal brain. Cancer Res. 1979 Aug;39(8):3235–3243. [PubMed] [Google Scholar]
  228. Wikstrand C. J., Bigner D. D. Surface antigens of human glioma cells shared with normal adult and fetal brain. Cancer Res. 1979 Aug;39(8):3235–3243. [PubMed] [Google Scholar]
  229. Wikstrand C. J., Mahaley M. S., Bigner D. D. Surface antigenic characteristics of human glial brain tumor cells. Cancer Res. 1977 Dec;37(12):4267–4275. [PubMed] [Google Scholar]
  230. Willson C. F., Normansell D. E., Netsky M. G. Antigenicity of fetal and adult cerebral tissue of man. Neurology. 1974 Aug;24(8):761–766. doi: 10.1212/wnl.24.8.761. [DOI] [PubMed] [Google Scholar]
  231. Winters W. D., Rich J. R. Human meningioma antigens. Int J Cancer. 1975 May 15;15(5):815–822. doi: 10.1002/ijc.2910150513. [DOI] [PubMed] [Google Scholar]
  232. Wood G. W., Morantz R. A. Immunohistologic evaluation of the lymphoreticular infiltrate of human central nervous system tumors. J Natl Cancer Inst. 1979 Mar;62(3):485–491. doi: 10.1093/jnci/62.3.485. [DOI] [PubMed] [Google Scholar]
  233. Wood W. C., Kornblith P. L., Quindlen E. A., Pollock L. A. Detection of humoral immune response to human brain tumors: specificity and reliability of microcytotoxicity assay. Cancer. 1979 Jan;43(1):86–90. doi: 10.1002/1097-0142(197901)43:1<86::aid-cncr2820430113>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  234. Woosley R. E., Mahaley M. S., Jr, Mahaley J. L., Miller G. M., Brooks W. H. Immunobiology of primary intracranial tumors. Part 3: Microcytotoxicity assays of specific immune responses of brain tumor patients. J Neurosurg. 1977 Dec;47(6):871–885. doi: 10.3171/jns.1977.47.6.0871. [DOI] [PubMed] [Google Scholar]
  235. Young H. F., Kaplan A. M. Cellular immune deficiency in patients with glioblastoma. Surg Forum. 1976;27(62):476–478. [PubMed] [Google Scholar]
  236. Young H. F., Sakalas R., Kaplan A. M. Inhibition of cell-mediated immunity in patients with brain tumors. Surg Neurol. 1976 Jan;5(1):19–23. [PubMed] [Google Scholar]
  237. de Moerloose P., Jeannet M., Martin-Achard A., de Tribolet N., Seiler R., Guanella N. HLA and glioma. Tissue Antigens. 1978 Aug;12(2):146–148. doi: 10.1111/j.1399-0039.1978.tb01311.x. [DOI] [PubMed] [Google Scholar]
  238. van der Meulen J. D., Houthoff H. J., Ebels E. J. Glial fibrillary acidic protein in human gliomas. Neuropathol Appl Neurobiol. 1978 May-Jun;4(3):177–190. doi: 10.1111/j.1365-2990.1978.tb00534.x. [DOI] [PubMed] [Google Scholar]
  239. von Motz I. P., Bots G. T., Endtz L. J. Astrocytoma in three sisters. Neurology. 1977 Nov;27(11):1038–1041. doi: 10.1212/wnl.27.11.1038. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES